A digital health startup that offers AI-powered clinical and drug prescription services for minor conditions
Evaro has raised €22M across 2 funding rounds from 6 investors, most recently a Series A round in Jan 2026. Based in London, UK; active in Healthtech. Data as of 6 Aug 2026.
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-01-27 | Series A | €21M | British Business Investments (BBI),Cornerstone VC,Exceptional Ventures,Simplyhealth Ventures | View deal → |
| 2024-01-31 | Seed | €1.4M | Cornerstone VC,Exceptional Ventures,Syndicate Room,the University of East Anglia | View deal → |
